Enabled by next-gen transdermal delivery technology, MitoSkin formulations work by targeting reactive oxygen species, membrane instability, and mitochondrial dysfunction. These subcellular pathologies reduce the body's ability to recover from disease and environmental stressors contributing to chronic illness and inflammation. Addressing these problems is key for maintaining young and healthy cells. Solutions that don't address these problems are simply covering them up.
Enterprise services in:
NAD+ Precursor Systemic Delivery
Liposomal Delivery
Polymer Drug Loading
Non-occlusive Transdermal Delivery
Mitochondria Density Augmentation
Microcavity Encapsulation
Raw Material Sourcing and Processing
Company Details
- Founded
- -
- Address
- Chicago, Il, Us
- Industry
- Biotechnology
- Website
- http://mitoskin.org
- Keywords
- in:.
- HQ
- Chicago, IL
Mitoskin Questions
Mitoskin's website is http://mitoskin.org
Mitoskin's LinkedIn profile is https://www.linkedin.com/company/mitoskin
Mitoskin's industry is
Biotechnology
Mitoskin's top competitors are
Gator Capital Management,
Normal,
Harvestcorp Technologies Inc,
Finite Robotics (Division Of Finite Farms Inc),
Operation Mourning Dove,
Beekon,
Heereco,
Finite Farms,
Mycionics Inc.,
Atlantis Capital, Llc.
Mitoskin's categories are Biotechnology
Mitoskin's founding year is 2021
